Clearstead Advisors’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$434 Buy
+15
New +$335 ﹤0.01% 2965
2025
Q4
Sell
-594
Closed -$12.8K 3136
2025
Q3
$12.8K Buy
594
+28
+5% +$636 ﹤0.01% 1838
2025
Q2
$12.5K Buy
+566
New +$12.4K ﹤0.01% 1811
2024
Q4
Sell
-187
Closed -$3.13K 2167
2024
Q3
$3.13K Hold
187
﹤0.01% 1781
2024
Q2
$5.35K Buy
+187
New +$5.63K ﹤0.01% 1678
2024
Q1
Sell
-35
Closed -$1.3K 1613
2023
Q4
$1.3K Hold
35
﹤0.01% 1363
2023
Q3
$1.19K Buy
+35
New +$1.32K ﹤0.01% 1336
2022
Q2
Sell
-42
Closed -$2K 1400
2022
Q1
$2K Buy
+42
New +$1.8K ﹤0.01% 1224
2021
Q4
Sell
-376
Closed -$21K 1397
2021
Q3
$21K Buy
+376
New +$20.8K ﹤0.01% 807

Other funds holding PGNY

Clearstead Advisors's PGNY Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Progyny (PGNY) in Q2 2026: 15 shares worth $434. The stake represents ﹤0.01% of the portfolio and ranks #2965 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in PGNY as recently as Q3 2025.

Clearstead Advisors first reported a position in PGNY in Q3 2021 and has held it in 9 quarters since. The position peaked at $21K in Q3 2021. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Clearstead Advisors held 15 shares of Progyny worth $434 as of Q2 2026.
  • Progyny was a new Clearstead Advisors position in Q2 2026.
  • Progyny made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2965 holding.
  • Clearstead Advisors first reported a position in Progyny in Q3 2021 and has held it in 9 quarters since.
  • Clearstead Advisors's Progyny position peaked at $21K in Q3 2021.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.